Tag: CKD

1. Stopping renin-angiotensin system inhibition in patients with advanced chronic kidney disease was associated with higher risk of mortality, major cardiovascular events, and lower risk of kidney replacement therapy. Evidence Rating Level: 2 (Good) Studies have shown that renin-angiotensin system inhibitors (RASi) are effective in delaying chronic kidney disease (CKD) progression. Angiotensin-converting enzyme...
1. Stopping renin-angiotensin system inhibition in patients with advanced chronic kidney disease was associated with higher risk of mortality, major cardiovascular events, and lower risk of kidney replacement therapy. Evidence Rating Level: 2 (Good) Studies have shown that renin-angiotensin system inhibitors (RASi) are effective in delaying chronic kidney disease (CKD) progression. Angiotensin-converting...
1. In patients with CKD, fixed low dose of erythropoietin provides similar efficacy outcomes, such as percentage of patients requiring transfusions, as titration-based dosing based on Hgb levels while decreasing cumulative dose of erythropoietin needed. Evidence Rating Level: 1 (Excellent) Chronic kidney disease (CKD) patients have parenchymal loss leading to decreased...
1. Ninety percent of older adults with advanced chronic kidney disease were found to have inappropriate prescriptions (i.e. medications contraindicated for elderly or for patients with CKD) in a median follow up of 2 years. 2. Following the introduction of pharmacists to a kidney care team, there may be a...
1. Urate reduction with allopurinol did not slow the decline of estimated glomerular filtration rate (eGFR) compared to the placebo treatment in patients with chronic kidney disease. 2. The urinary albumin:creatinine ratio was shown not to be significantly different between the treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Increased risk...